Celldex Therapeutics
CLDX
#4492
Rank
โ‚น240.06 B
Marketcap
โ‚น3,058
Share price
-1.52%
Change (1 day)
69.66%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚น48.21 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are โ‚น48.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚น52.33 B-23.01%
2024-12-31โ‚น67.97 B75.35%
2023-12-31โ‚น38.76 B32.8%
2022-12-31โ‚น29.18 B-11.81%
2021-12-31โ‚น33.09 B91.89%
2020-12-31โ‚น17.24 B96.75%
2019-12-31โ‚น8.76 B-19.53%
2018-12-31โ‚น10.89 B-45.94%
2017-12-31โ‚น20.15 B-22.64%
2016-12-31โ‚น26.05 B16.12%
2015-12-31โ‚น22.43 B42.72%
2014-12-31โ‚น15.71 B-26.7%
2013-12-31โ‚น21.44 B211.96%
2012-12-31โ‚น6.87 B32.6%
2011-12-31โ‚น5.18 B5.22%
2010-12-31โ‚น4.92 B-24.36%
2009-12-31โ‚น6.51 B94.15%
2008-12-31โ‚น3.35 B811.82%
2007-12-31โ‚น0.36 B-86.49%
2006-12-31โ‚น2.72 B66%
2005-12-31โ‚น1.64 B-17.31%
2004-12-31โ‚น1.98 B39.17%
2003-12-31โ‚น1.42 B-15.64%
2002-12-31โ‚น1.68 B-34.53%
2001-12-31โ‚น2.58 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚น19.580 T 40,509.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น8.724 T 17,993.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น7.852 T 16,185.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
โ‚น342.74 B 610.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น22.05 B-54.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น137.78 B 185.77%๐Ÿ‡บ๐Ÿ‡ธ USA